_:n751ef51a512e4a609012b9388c42a4b0xb0
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>
<https://theperfectenemy.com/atriva-therapeutics-announces-topline-results-from-the-proof-of-concept-poc-phase-2a-respire-study-zapnometinib-in-patients-hospitalized-with-covid-19/>